IART Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Integra Lifesciences Holdings Corp (IART) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock's technical indicators are bearish, options sentiment is neutral, and the company's financial performance shows declining profitability. While there is an upcoming earnings announcement, the lack of significant positive catalysts or trading signals suggests holding off on purchasing this stock for now.
The stock's MACD is slightly positive but contracting, RSI is neutral at 37.659, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels indicate the stock is trading near its support (S1: 10.689). Overall, the technical indicators suggest a bearish trend.
Upcoming Q4 and full-year 2025 earnings announcement and management conference call on February 26, 2026, which could provide clarity on the company's strategy and performance.
Declining net income (-49.47% YoY) and EPS (-50.00% YoY) in Q3 2025, along with a slight drop in gross margin. No significant insider or hedge fund trading activity, and no recent congress trading data.
In Q3 2025, revenue increased by 5.57% YoY to $402.06M, but net income dropped significantly to -$5.40M (-49.47% YoY), and EPS declined to -$0.07 (-50.00% YoY). Gross margin slightly decreased to 56.24%. Overall, the financial performance highlights growth in revenue but significant profitability challenges.
No recent analyst rating or price target changes were provided. Wall Street sentiment appears neutral, with no strong pros or cons highlighted.
